Strengthening HIV therapy and care in rural Tanzania affects rates of viral suppression.

about

Strengthening HIV therapy and care in rural Tanzania affects rates of viral suppression.

Item

http://www.wikidata.org/entity/Q39311484

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Strengthening HIV therapy and care in rural Tanzania affects rates of viral suppression.

@en

Strengthening HIV therapy and care in rural Tanzania affects rates of viral suppression.

@nl

type

Item

label

Strengthening HIV therapy and care in rural Tanzania affects rates of viral suppression.

@en

Strengthening HIV therapy and care in rural Tanzania affects rates of viral suppression.

@nl

prefLabel

Strengthening HIV therapy and care in rural Tanzania affects rates of viral suppression.

@en

Strengthening HIV therapy and care in rural Tanzania affects rates of viral suppression.

@nl

P1476

Strengthening HIV therapy and care in rural Tanzania affects rates of viral suppression.

@en

P2093

Alex J Ntamatungiro

http://www.w3.org/2001/XMLSchema#string

Ingrid Felger

http://www.w3.org/2001/XMLSchema#string

KIULARCO Study Group

http://www.w3.org/2001/XMLSchema#string

Lukas Muri

http://www.w3.org/2001/XMLSchema#string

Stefan Erb

http://www.w3.org/2001/XMLSchema#string

Tracy R Glass

http://www.w3.org/2001/XMLSchema#string

P2860

HIV drug resistance and its impact on antiretroviral therapy in Chinese HIV-infected patients

High prevalence of the K65R mutation in HIV-1 subtype C infected patients failing tenofovir-based first-line regimens in South Africa

Virological efficacy and emergence of drug resistance in adults on antiretroviral treatment in rural Tanzania.

Impact and programmatic implications of routine viral load monitoring in Swaziland.

Durability of antiretroviral therapy and predictors of virologic failure among perinatally HIV-infected children in Tanzania: a four-year follow-up.

Virologic and immunologic failure, drug resistance and mortality during the first 24 months postpartum among HIV-infected women initiated on antiretroviral therapy for life in the Mitra plus Study, Dar es Salaam, Tanzania

Antiretroviral drug resistance in HIV-1-infected patients experiencing persistent low-level viremia during first-line therapy

A Bundle of Services Increased Ascertainment of Tuberculosis among HIV-Infected Individuals Enrolled in a HIV Cohort in Rural Sub-Saharan Africa

Impact of genotypic drug resistance mutations on clinical and immunological outcomes in HIV-infected adults on HAART in West Africa

Impact of HIV drug resistance on virologic and immunologic failure and mortality in a cohort of patients on antiretroviral therapy in China.

P304

2069-2074

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JAC/DKX095

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-04-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28387865

http://www.w3.org/2001/XMLSchema#string

P921

An Tansáin